Biopharma Daily Stock Updates - 10/15/21

$PFE -0.5% Pfizer and BioNTech Submit Data to EMA for the Vaccination of Children 5 to <12 Years of Age with COMIRNATY®. source

$RVNC -29% Revance Provides Regulatory Update on DaxibotulinumtoxinA for Injection for the Treatment of Moderate to Severe Glabellar (Frown) Lines. source

$JNJ +1% Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee. source

$RHHBY +1.5% US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer. source

$AVDL -16% Avadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with Narcolepsy. source

$CABA -7% Cabaletta Bio Announces Presentation of Preclinical Data Supporting PLA2R-CAART as a Potential Precision Therapy for Antigen-Specific B Cell Depletion. source

$NVAX -5% Novavax to Participate in World Vaccine Congress Europe. source

$KDNY -.5% CHINOOK THERAPEUTICS ANNOUNCES UPCOMING DATA PRESENTATIONS AND INVESTOR CONFERENCE CALL DURING THE AMERICAN SOCIETY OF NEPHROLOGY (ASN) KIDNEY WEEK 2021. source

$DRNA +1% Dicerna Announces Data to Be Presented at American Society of Nephrology (ASN) Kidney Week 2021. source

$SYBX +.5% Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021. source

$PLX -3% Protalix Biotherapeutics and Chiesi Global Rare Diseases Announce Final Dosing of Last Patient in Phase III BALANCE Clinical Trial PRX-102 for the Treatment of Fabry Disease. source

$VIR -3% Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at AASLD’s The Liver Meeting® 2021. source

$ALBO +.5% Albireo to Showcase New Data at AASLD The Liver Meeting® 2021. source

$ASND -.2%Ascendis Pharma A/S Announces U.S. Commercial Launch of SKYTROFA® (Lonapegsomatropin-tcgd), the First and Only FDA Approved Once-Weekly Treatment for Pediatric Growth Hormone Deficiency. source

$APLS -2% Apellis and Sobi Receive Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of PNH. source

$LVTX -7% LAVA Therapeutics Receives FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia. source

$RETA -1% Reata Pharmaceuticals Announces Presentations at the American Society of Nephrology Kidney Week 2021. source

$EBS -2% Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP. source

$AZN +1% Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial in 1st-line unresectable liver cancer. source

$SRPT +1% Raised at $81/sh set to close on 10/18/21. source

$GERN 0% Geron to Host a Virtual Investor Event in November. source

Posted by FS/DV